Recent animal studies show senolytic vaccines reduce tumor growth by up to 50% when combined with anti-PD-L1, with clinical trials advancing for lung cancer and melanoma. Emerging senolytic vaccines t...
Nanotechnology breakthrough shows curcumin-loaded cubosomes outperform conventional arthritis drugs with fewer side effects, as FDA fast-tracks review for new therapies. Recent clinical trials demonst...
New research shows herbal cubosomes loaded with curcumin and boswellia outperform conventional arthritis drugs while reducing side effects, offering hope for millions of patients. Groundbreaking cubos...
New research shows herbal cubosomes deliver potent anti-inflammatory compounds more effectively than conventional arthritis drugs, with clinical trials demonstrating superior patient outcomes. Cutting...